Affiliation:
1. Authors' Affiliation: Department of Radiation Oncology, Cancer Biology Division, Washington University in Saint Louis School of Medicine, Saint Louis, Missouri
Abstract
AbstractBlood vessel formation plays an essential role in many physiologic and pathologic processes, including normal tissue growth and healing, as well as tumor progression. Endothelial progenitor cells (EPC) are a subtype of stem cells with high proliferative potential that are capable of differentiating into mature endothelial cells, thus contributing to neovascularization in tumors. In response to tumor-secreted cytokines, EPCs mobilize from the bone marrow to the peripheral blood, home to the tumor site, and differentiate to mature endothelial cells and secrete proangiogenic factors to facilitate vascularization of tumors. In this review, we summarize the expression of surface markers, cytokines, receptors, adhesion molecules, proteases, and cell signaling mechanisms involved in the different steps (mobilization, homing, and differentiation) of EPC trafficking from the bone marrow to the tumor site. Understanding the biologic mechanisms of EPC cell trafficking opens a window for new therapeutic targets in cancer. Clin Cancer Res; 19(13); 3360–8. ©2013 AACR.
Publisher
American Association for Cancer Research (AACR)
Reference74 articles.
1. Endothelial progenitor cells;Khakoo;Annu Rev Med,2005
2. Mechanisms of angiogenesis;Risau;Nature,1997
3. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique;Greenblatt;J Natl Cancer Inst,1968
4. Angiogenesis in life, disease and medicine;Carmeliet;Nature,2005
5. Tumor angiogenesis: therapeutic implications;Folkman;N Engl J Med,1971
Cited by
101 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献